We´ve been working with Cenibra´s "looking at cells" technologies for a while now and have found that generating publication-grade imaging data has become a lot faster, very efficient and the analyses definitely more precise. Specifically, with Celigo and CQ1 we see a winning combination of complementary tools for our work with 2D and 3D cell culture models on both cellular and subcellular level.

In our stem cell centre Celigo has established itself as one of the most important instruments for the analysis of stem cell culture assays as well as differentiated cell assays (e.g. cardiomyocytes). The analyses are accurate, time-saving and the images are of high quality. We are very satisfied and the service is unique. With the Cellometer we also use a very precise and efficient routine tool for daily cell counting.

We like the CQ1 a lot, especially the speed of image acquisition and the possibility of simultaneous analysis. An immense plus for us is the great support we get from Cenibra, which was one of the main factors that convinced us to buy the device. We never experienced this kind of support with other devices before.

We have been working with CENIBRA for almost two years now and we can highly recommend working with them. The interaction with Michael and his colleagues is always very pleasant. The CQ1 enables us to generate very interesting data. This instrument is very reliable for long term live cell imaging and provides high quality images that can be analyzed to generate quantitative data. For us it is very important to know that we can count on CENIBRA whenever we need support not only with technical problems that may occur but also with specific image analysis questions.

For some time now, we have been using the MP-SPR Navi 420A Ilves to perform surface plasmon resonance spectroscopy for our research in biomolecular interactions in drug development. The "ILVES" is an ideal addition to our range of biochemical and biophysical assays. In addition, the support we receive from Cenibra with technical questions and assay development, is unique. The advantages of the "ILVES" and the cooperation with Cenibra definitely accelerate the generation of meaningful results for our research.

Our Diagnostic Systems research group at the University of Applied Sciences and Arts Western Switzerland (HES-SO Valais-Wallis) is dedicated to conceiving novel solutions to unmet needs in point-of-care diagnostics, thus bringing the laboratory closer to the patients. The Bionavis MP-SPR Navi 210A is the ideal platform to evaluate the affinity and kinetics of our developed molecules and bioconjugates. With Cenibra's commitment to supporting its customers, we can efficiently create new SPR assay methods and tackle the challenges of our research projects.